Zenas Looks To Target Progressive Multiple Sclerosis Via InnoCare Deal

 
• By Joseph Haas
  
Zenas will take up an InnoCare MS candidate that Biogen returned in 2023 • Source: Shutterstock

More from Deals

More from Business